FDA Approves New Multiple Sclerosis Drug

The Food and Drug Administration has approved a new drug for adults with relapsing forms of Multiple Sclerosis, or MS.

Patients taking the new drug, called Tecfidera, experienced fewer relapses and a delay in progression of the disease. MS is an autoimmune disease that disrupts communication between the brain and other parts of the body.

Patients experience muscle weakness and difficulty with coordination and balance. The symptoms get progressively worse with time, and currently there is no cure.


We encourage commenting on our stories to give you a chance to express your opinion. We rely upon the online community to report abuse. Repeat violators may be banned from posting comments. CLICK HERE for the witn.com guidelines for posting comments. powered by Disqus